Dopamine/d5w 1.6mg/ml Inj , 500ml

Manufacturer BAXTER Active Ingredient Dopamine(DOE pa meen) Pronunciation DOE-pa-meen
It is used to treat heart failure (weak heart).It is used to treat low blood pressure. It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Vasopressor; Inotropic Agent
đŸ§Ŧ
Pharmacologic Class
Adrenergic Agonist (Alpha-1, Beta-1, Dopaminergic)
🤰
Pregnancy Category
Category C
✅
FDA Approved
May 1973
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Dopamine is a medication given through an IV (intravenous) line to help your heart pump stronger and to raise your blood pressure. It's often used in emergency situations when your body isn't getting enough blood flow to vital organs.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and adhere to all guidelines provided. This drug is administered via infusion into a vein over a specified period of time.

For storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to keep this medication at home.

If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
💡

Lifestyle & Tips

  • Not applicable as this is an acute, hospital-administered medication.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Initial: 2-5 mcg/kg/min IV infusion, titrated to desired hemodynamic response. Usual maintenance: 5-20 mcg/kg/min.
Dose Range: 0.5 - 50 mg

Condition-Specific Dosing:

renal_vasodilation: 0.5-3 mcg/kg/min
cardiac_inotropic: 3-10 mcg/kg/min
vasopressor: 10-20 mcg/kg/min (up to 50 mcg/kg/min in severe cases)
đŸ‘ļ

Pediatric Dosing

Neonatal: Initial: 2-5 mcg/kg/min IV infusion, titrated to desired hemodynamic response. Usual maintenance: 5-20 mcg/kg/min.
Infant: Initial: 2-5 mcg/kg/min IV infusion, titrated to desired hemodynamic response. Usual maintenance: 5-20 mcg/kg/min.
Child: Initial: 2-5 mcg/kg/min IV infusion, titrated to desired hemodynamic response. Usual maintenance: 5-20 mcg/kg/min.
Adolescent: Initial: 2-5 mcg/kg/min IV infusion, titrated to desired hemodynamic response. Usual maintenance: 5-20 mcg/kg/min.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment; titrate to effect based on hemodynamic response and urine output.
Moderate: No specific adjustment; titrate to effect based on hemodynamic response and urine output.
Severe: No specific adjustment; titrate to effect based on hemodynamic response and urine output.
Dialysis: Dopamine is rapidly metabolized and not significantly removed by dialysis. Titrate to effect.

Hepatic Impairment:

Mild: No specific adjustment; titrate to effect.
Moderate: No specific adjustment; titrate to effect.
Severe: No specific adjustment; titrate to effect.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Dopamine is a precursor to norepinephrine with dose-dependent effects. At low doses (0.5-3 mcg/kg/min), it stimulates dopaminergic D1 receptors in renal, mesenteric, coronary, and cerebral vascular beds, causing vasodilation and increased renal blood flow and urine output. At intermediate doses (3-10 mcg/kg/min), it primarily stimulates beta-1 adrenergic receptors, increasing myocardial contractility, heart rate, and cardiac output. At high doses (>10 mcg/kg/min), it primarily stimulates alpha-1 adrenergic receptors, causing vasoconstriction, increasing systemic vascular resistance (SVR) and blood pressure.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (IV)
Tmax: Rapid (within minutes of IV infusion initiation)
FoodEffect: Not applicable (IV administration)

Distribution:

Vd: 0.89 L/kg
ProteinBinding: Not available (low)
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 2 minutes (range 1-5 minutes)
Clearance: Not available (rapid metabolism)
ExcretionRoute: Renal (as inactive metabolites)
Unchanged: <10%
âąī¸

Pharmacodynamics

OnsetOfAction: Within 5 minutes
PeakEffect: Within 5-10 minutes
DurationOfAction: Less than 10 minutes after discontinuation of infusion

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Attention Immediately

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Shortness of breath
Chest pain or pressure
Abnormal heartbeat (fast, slow, or irregular)
Cool or pale arm or leg
Changes in skin color to black or purple
Difficulty urinating or changes in urine output

If you notice any of the following symptoms at the injection site, inform your nurse immediately:

Redness
Burning
Pain
Swelling
Blisters
Skin sores
Leaking of fluid

This medication can cause tissue damage if it leaks from the vein.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:

Upset stomach or vomiting
Headache
Anxiety
* Goosebumps

This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • As this medication is administered in a hospital setting with continuous monitoring, patients are not typically responsible for self-monitoring for specific warning symptoms. Any changes in condition will be monitored by healthcare staff.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including any symptoms.
If you have been diagnosed with pheochromocytoma, a type of adrenal gland tumor.
If you have a history of irregular or rapid heartbeat.
If you have low levels of potassium or magnesium in your blood.
If you have low blood volume or a condition that causes acidic blood (acidosis).

This list is not exhaustive, and it is crucial to discuss all your health problems and medications with your doctor. Provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
Your complete medical history, including any health problems

Your doctor will assess the safety of taking this medication with your existing health conditions and medications. Do not initiate, stop, or modify the dosage of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Be sure to discuss any concerns or questions with your doctor.

Additionally, it is crucial to check your blood pressure as instructed by your doctor.

Stopping this medication too quickly can lead to low blood pressure, which may cause severe dizziness or fainting. If you experience any of these symptoms, contact your doctor immediately.

If you have a known allergy to sulfites, consult with your doctor before taking this medication, as some products may contain sulfites.

If you are pregnant, planning to become pregnant, or are breastfeeding, it is vital to discuss the potential benefits and risks of this medication with your doctor to ensure the best possible outcome for you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Excessive increase in blood pressure (hypertension)
  • Tachycardia (rapid heart rate)
  • Arrhythmias (irregular heartbeats)
  • Peripheral vasoconstriction (cold, pale extremities)
  • Headache
  • Nausea/Vomiting

What to Do:

Management involves immediate discontinuation or reduction of the infusion rate. Supportive measures, including alpha-adrenergic blocking agents (e.g., phentolamine) for severe hypertension or extravasation, may be administered. Call 1-800-222-1222 (Poison Control) for further guidance if needed in a non-clinical setting.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - may cause hypertensive crisis
  • Cyclopropane and halogenated hydrocarbon anesthetics - may sensitize myocardium to arrhythmias
🔴

Major Interactions

  • Beta-adrenergic blocking agents (e.g., propranolol, metoprolol) - may antagonize cardiac effects of dopamine
  • Alpha-adrenergic blocking agents (e.g., phentolamine) - may antagonize peripheral vasoconstriction
  • Tricyclic antidepressants (TCAs) - may potentiate pressor effects
  • Phenytoin - may cause hypotension and bradycardia
🟡

Moderate Interactions

  • Diuretics - may have additive effects on urine output
  • Oxytocic drugs - may cause severe persistent hypertension

Monitoring

đŸ”Ŧ

Baseline Monitoring

Vital Signs (HR, BP, RR, Temp)

Rationale: To establish baseline hemodynamic status and guide initial dosing.

Timing: Prior to initiation of infusion

Electrocardiogram (ECG)

Rationale: To assess cardiac rhythm and identify pre-existing arrhythmias.

Timing: Prior to initiation of infusion

Urine Output

Rationale: To assess renal perfusion and response to dopamine's renal effects.

Timing: Prior to initiation of infusion

Central Venous Pressure (CVP) / Pulmonary Artery Wedge Pressure (PAWP) / Cardiac Output (CO)

Rationale: For comprehensive hemodynamic assessment in critically ill patients.

Timing: Prior to initiation of infusion (if invasive monitoring is in place)

Serum Lactate

Rationale: To assess tissue perfusion and severity of shock.

Timing: Prior to initiation of infusion

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Continuously (arterial line preferred) or every 5-15 minutes

Target: Individualized, typically MAP >65 mmHg or SBP >90 mmHg

Action Threshold: Adjust infusion rate to maintain target BP; investigate hypotension/hypertension

Heart Rate (HR)

Frequency: Continuously

Target: Individualized, avoid excessive tachycardia

Action Threshold: Adjust infusion rate if HR increases significantly or arrhythmias develop

Electrocardiogram (ECG)

Frequency: Continuous monitoring

Target: Normal sinus rhythm, absence of significant arrhythmias

Action Threshold: Investigate and manage new arrhythmias (e.g., ventricular ectopy, tachycardia)

Urine Output

Frequency: Hourly

Target: >0.5 mL/kg/hr

Action Threshold: Investigate oliguria/anuria; consider fluid status and other interventions

Peripheral Perfusion (skin color, temperature, capillary refill)

Frequency: Every 1-4 hours

Target: Warm, dry, good capillary refill

Action Threshold: Assess for signs of vasoconstriction or ischemia (e.g., mottling, cold extremities)

Hemodynamic Parameters (CVP, PAWP, CO, SVR)

Frequency: As clinically indicated (e.g., every 1-4 hours or with dose changes)

Target: Individualized based on patient's condition and goals

Action Threshold: Adjust infusion rate or consider other interventions based on trends

Acid-Base Status (ABG/VBG)

Frequency: As clinically indicated (e.g., every 4-8 hours)

Target: pH 7.35-7.45

Action Threshold: Address metabolic acidosis, which can impair catecholamine effectiveness

đŸ‘ī¸

Symptom Monitoring

  • Chest pain
  • Palpitations
  • Dyspnea
  • Headache
  • Nausea/Vomiting
  • Peripheral ischemia (e.g., cold, mottled extremities, pain)
  • Extravasation at infusion site (swelling, pain, blanching)

Special Patient Groups

🤰

Pregnancy

Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks. Use only if the potential benefit justifies the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: Potential for adverse effects on fetal development, but human data are limited.
Second Trimester: Potential for adverse effects on fetal development, but human data are limited.
Third Trimester: Potential for adverse effects on fetal development, but human data are limited. May affect uterine blood flow.
🤱

Lactation

It is not known whether dopamine is excreted in human milk. Due to the potential for serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Risk is generally considered low due to poor oral absorption and short half-life.

Infant Risk: Low risk, but caution advised. Monitor infant for signs of adverse effects (e.g., irritability, feeding difficulties).
đŸ‘ļ

Pediatric Use

Dopamine is used in pediatric patients for similar indications as adults, with dosing based on weight (mcg/kg/min). Close monitoring of hemodynamic parameters is essential. Neonates may have reduced capacity for metabolism and excretion.

👴

Geriatric Use

Elderly patients may be more sensitive to the effects of dopamine, particularly the pressor and chronotropic effects, and may be more prone to adverse reactions such as arrhythmias and excessive vasoconstriction. Start with lower doses and titrate slowly with careful monitoring of hemodynamic parameters and renal function.

Clinical Information

💎

Clinical Pearls

  • Dopamine exhibits dose-dependent effects: low doses for renal vasodilation, intermediate for inotropy, and high for vasoconstriction.
  • Administer via a central venous catheter whenever possible due to the risk of extravasation and tissue necrosis. If extravasation occurs, infiltrate the area with phentolamine.
  • Always titrate dopamine infusion to the desired hemodynamic response, not to a fixed dose.
  • Correct hypovolemia prior to initiating dopamine, unless it's an emergency where immediate pressor support is needed.
  • Monitor for signs of peripheral ischemia (e.g., mottling, cold extremities) especially at higher doses.
  • Dopamine can increase myocardial oxygen demand, which may be detrimental in patients with coronary artery disease.
🔄

Alternative Therapies

  • Norepinephrine (Levophed) - primary vasopressor for septic shock
  • Epinephrine (Adrenalin) - vasopressor and inotropic agent
  • Phenylephrine (Neo-Synephrine) - pure alpha-1 agonist, vasopressor
  • Dobutamine (Dobutrex) - primarily inotropic agent
  • Milrinone (Primacor) - phosphodiesterase inhibitor, inotropic and vasodilator
💰

Cost & Coverage

Average Cost: Variable, depends on hospital contract and volume per 500ml solution
Generic Available: Yes
Insurance Coverage: Typically covered under hospital inpatient services; not a retail pharmacy drug.
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, do not flush medications down the toilet or pour them down the drain. If you are unsure about the proper disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.